- Home
- SFWL vs XBIT Comparison
SFWL vs XBIT Comparison
Compare SFWL & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- XBIT
- Stock Information
- Founded
- SFWL 2001
- XBIT 2005
- Country
- SFWL China
- XBIT United States
- Employees
- SFWL N/A
- XBIT N/A
- Industry
- SFWL Trucking Freight/Courier Services
- XBIT Pharmaceuticals and Biotechnology
- Sector
- SFWL Industrials
- XBIT Health Care
- Exchange
- SFWL Nasdaq
- XBIT Nasdaq
- Market Cap
- SFWL 82.3M
- XBIT 86.3M
- IPO Year
- SFWL 2023
- XBIT 2015
- Fundamental
- Price
- SFWL $0.99
- XBIT $2.85
- Analyst Decision
- SFWL
- XBIT
- Analyst Count
- SFWL 0
- XBIT 0
- Target Price
- SFWL N/A
- XBIT N/A
- AVG Volume (30 Days)
- SFWL 13.0K
- XBIT 43.4K
- Earning Date
- SFWL 09-04-2025
- XBIT 08-11-2025
- Dividend Yield
- SFWL N/A
- XBIT N/A
- EPS Growth
- SFWL 4.79
- XBIT N/A
- EPS
- SFWL 0.13
- XBIT N/A
- Revenue
- SFWL $504,158,000.00
- XBIT N/A
- Revenue This Year
- SFWL N/A
- XBIT N/A
- Revenue Next Year
- SFWL N/A
- XBIT N/A
- P/E Ratio
- SFWL $7.48
- XBIT N/A
- Revenue Growth
- SFWL 24.75
- XBIT N/A
- 52 Week Low
- SFWL $0.86
- XBIT $2.50
- 52 Week High
- SFWL $1.60
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- SFWL 51.50
- XBIT 46.84
- Support Level
- SFWL $0.95
- XBIT $2.79
- Resistance Level
- SFWL $1.02
- XBIT $2.92
- Average True Range (ATR)
- SFWL 0.03
- XBIT 0.15
- MACD
- SFWL 0.00
- XBIT -0.02
- Stochastic Oscillator
- SFWL 72.80
- XBIT 17.54
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.